← Open Payments lookup

DUN-WEAH MAYSON: Open Payments

NPI 1083481352 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,048 in 34 payments from 9 companies in 2025. Trend: 2023 $16 · 2024 $1,477 · 2025 $1,048

Food & beverage: $1,048
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.5$207
Vanda Pharmaceuticals Inc.7$191
ABBVIE INC.4$188
Janssen Pharmaceuticals, Inc5$171
Otsuka America Pharmaceutical, Inc.5$102
Alkermes, Inc.4$92
E.R. Squibb & Sons, L.L.C.2$44
Neurocrine BioSciences, Inc.1$29
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25

Products named: FANAPT, VRAYLAR, INVEGA SUSTENNA, AUSTEDO XR, ARISTADA, ABILIFY ASIMTUFII, UZEDY, COBENFY.

Industry payments across PA — which companies pay providers there.